Itami, Japan

Masako Kajihara



Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 89(Granted Patents)


Location History:

  • Hyogo Prefecture, JP (1998)
  • Itami, JP (2004 - 2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Masako Kajihara: Innovator in Sustained-Release Drug Formulations

Introduction

Masako Kajihara is a prominent inventor based in Itami, Japan. She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of sustained-release drug delivery systems. With a total of 5 patents to her name, her work has the potential to greatly impact medical treatments.

Latest Patents

Kajihara's latest patents focus on sustained-release drug formulations for implantation. These inventions relate to a formulation that achieves controlled releases of active ingredients. The formulations comprise various combinations of particles, including those containing active ingredients, carbonates, and substances that react with carbonates in an aqueous solution to generate carbon dioxide. This innovative approach allows for improved drug delivery and efficacy.

Career Highlights

Throughout her career, Masako Kajihara has worked with notable companies in the pharmaceutical industry. She has been associated with Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. Her experience in these organizations has contributed to her expertise in drug formulation and development.

Collaborations

Kajihara has collaborated with esteemed colleagues such as Akihiko Sano and Hiroo Maeda. These partnerships have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Masako Kajihara is a trailblazer in the field of sustained-release drug formulations. Her innovative patents and collaborations reflect her dedication to advancing pharmaceutical science. Her contributions are poised to make a lasting impact on drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…